In world’s first genetically engineered marsupials, scientists get a fresh window into human biology
By Megan Molteni,
STAT
| 07. 21. 2021
Photo licensed for use by CC BY-SA 2.5
When the pile of opossums arrived at John VandeBerg’s lab from the Smithsonian’s National Zoo in 1978, the geneticist had an ambitious plan for the soft-eyed, hamster-sized animals. He wanted to domesticate them to live in a lab anywhere on the planet. Mice were well and good, but imagine what biomedical insights might be lurking inside marsupials, he thought. Their young, rather than being encased inside a uterus, develop attached to a nipple in a pouch or on a belly where they’re much easier to observe.
VandeBerg succeeded, and today manages the largest Monodelphis domestica colony in the world at the University of Texas Rio Grande Valley School of Medicine. More than a dozen labs have taken up research projects with the gray short-tailed opossums, who hail from South America. But the same quirk that makes them a compelling model organism has also made them more difficult to study than he once imagined.
Shortly after ovulation, marsupial moms secrete layers of mucus and protein around their eggs, covering them in a hard...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...